The multiple sclerosis (MS) risk factors smoking and remote Epstein-Barr virus (EBV) infection have been suggested to interact statistically, but the results are conflicting. In a prospective study on 192 MS cases and 384 matched controls, we analysed levels of cotinine as a marker of smoke exposure, and Epstein-Barr Nuclear Antigen-1 antibody reactivity. We assessed interaction on the additive and multiplicative scales, and estimated the effects of the risk factors across strata of each other. The results suggest that a negative interaction may be present in samples drawn at a young age, and a positive interaction among older subjects.
SalzerJHallmansGNyströmM. Smoking as a risk factor for multiple sclerosis. Mult Scler2013; 8: 1022–1027.
2.
WingerchukDM. Smoking: Effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord2012; 5: 13–22.
3.
SalzerJNyströmMHallmansG. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler. Epub ahead of print 2 April 2013. DOI: 10.1177/1352458513483888.
4.
SimonKCvan der MeiIAMungerKL. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology2010; 74: 1365–1371.
5.
SundqvistESundströmPLindenM. Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology2012; 79: 1363–1368.
6.
RiiseTPugliattiMCasettaI. Negative interaction between smoking and infectious mononucleosis in the risk of MS. ECTRIMS 5th Joint Triennial Congress, Amsterdam, The Netherlands, 19–22 October 2011, abstract no. 131.
7.
SalzerJHallmansGNyströmM. Vitamin D as a protective factor in multiple sclerosis. Neurology2012; 79: 2140–2145.
8.
VineisPAiroldiLVegliaF. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ2005; 330: 277–281.
